Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-16-014674
Filing Date
2016-11-09
Accepted
2016-11-09 16:53:08
Documents
39
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 215367
2 ex3-5.htm EX-3.5 2560
3 ex3-5_001.jpg GRAPHIC 50520
4 ex3-5_002.jpg GRAPHIC 85474
5 ex31-1.htm EX-31.1 15752
6 ex31-2.htm EX-31.2 15834
7 ex32-1.htm EX-32.1 8360
8 image_001.jpg GRAPHIC 10203
  Complete submission text file 0001493152-16-014674.txt   1278447

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE vapa-20160930.xml EX-101.INS 81054
10 XBRL SCHEMA FILE vapa-20160930.xsd EX-101.SCH 14926
11 XBRL CALCULATION FILE vapa-20160930_cal.xml EX-101.CAL 22334
12 XBRL DEFINITION FILE vapa-20160930_def.xml EX-101.DEF 45853
13 XBRL LABEL FILE vapa-20160930_lab.xml EX-101.LAB 109918
14 XBRL PRESENTATION FILE vapa-20160930_pre.xml EX-101.PRE 89182
Mailing Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419
Business Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419 612-812-2037
VapAria Corp (Filer) CIK: 0001479915 (see all company filings)

EIN.: 271521364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55470 | Film No.: 161984923
SIC: 2834 Pharmaceutical Preparations